|
Market Closed -
Nasdaq
16:00:00 2026-09-03 EDT
|
5-day change | 1st Jan Change | ||
| 12.68 USD | -0.63% |
|
-3.28% | +41.05% |
| 08-06 | Intellia Therapeutics, Inc., Q2 2026 Earnings Call, Aug 06, 2026 | |
| 08-06 | Wedbush Adjusts Intellia Therapeutics Price Target to $12 From $17, Maintains Neutral Rating | MT |
| Market Cap | 1.78B 1.53B 1.43B 1.31B 2.45B 168B 2.47B 16.97B 6.61B 85.84B 6.67B 6.53B 276B | P/E 2026 * |
-3.97x | P/E 2027 * | -4.8x |
|---|---|---|---|---|---|
| Enterprise Value | 1.44B 1.24B 1.16B 1.06B 1.98B 136B 2B 13.74B 5.35B 69.5B 5.4B 5.28B 224B | EV / Sales 2026 * |
27.7x | EV / Sales 2027 * | 11.2x |
| Free-Float |
96.16% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| NTLA | Delayed | |
CBOE
| NTLA | Real-time | |
|
Tradegate
| 38I | Real-time | |
|
London S.E.
| 0JBU | Delayed | |
|
Berne S.E.
| 38I | End-of-day quote | |
|
Boerse Muenchen
| 38I | Real-time | |
|
Börse Stuttgart
| 38I | Delayed | |
|
Xetra
| 38I | Delayed | |
|
Deutsche Boerse AG
| 38I | Delayed |
Last Transcript : Intellia Therapeutics, Inc.
| 1 day | -0.63% | ||
| 1 week | -3.28% | ||
| Current month | -0.39% | ||
| 1 month | +17.73% | ||
| 3 months | -2.61% | ||
| 6 months | -6.80% | ||
| Current year | +41.05% |
| 1 week | 12.28 |  | 13.13 |
| 1 month | 10.64 | | 13.73 |
| Current year | 9.05 | | 18.48 |
| 1 year | 7.95 | | 28.25 |
| 3 years | 5.9 | | 38.71 |
| 5 years | 5.9 | | 180.59 |
| 10 years | 5.9 | | 202.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Leonard
CEO | Chief Executive Officer | 68 | 2017-12-31 |
Edward Dulac
DFI | Director of Finance/CFO | 51 | 2024-07-21 |
Kristy Wood
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
John Leonard
BRD | Director/Board Member | 68 | 2014-06-30 |
Frank Verwiel
CHM | Chairman | 63 | 2020-01-31 |
Jesse Goodman
BRD | Director/Board Member | 74 | 2018-10-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/21/26 | Sell | Chief Executive Officer | -2,785 | 0.0020% | ||
| 7/22/26 | Sell | Chief Financial Officer | -8,111 | 0.0058% | ||
| 7/2/26 | Sell | Chief Financial Officer | -4,677 | 0.0033% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.63% | -3.28% | +8.28% | -66.36% | 1.79B | |
| -0.24% | -1.09% | +2.00% | +18.17% | 50.14B | |
| +0.78% | -4.65% | +430.22% | +501.63% | 44.85B | |
| +2.95% | +3.52% | +47.12% | +21.08% | 43.43B | |
| +0.25% | -2.63% | +7.86% | +73.60% | 41.14B | |
| +0.43% | -2.20% | +14.55% | +49.08% | 32.92B | |
| +1.43% | +8.73% | - | - | 17.56B | |
| +0.06% | -2.97% | +23.31% | +116.96% | 16.55B | |
| +0.93% | +0.63% | +16.86% | +29.70% | 14.65B | |
| +0.54% | -1.03% | +80.71% | +39.94% | 13.93B | |
| Average | +0.65% | -0.86% | +70.10% | +87.09% | 27.69B | |
| Weighted average by Cap. | +0.80% | -0.97% | +92.58% | +122.50% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 51.88M 44.64M 41.89M 38.33M 71.53M 4.9B 72.1M 496M 193M 2.51B 195M 191M 8.07B | 125M 108M 101M 92.69M 173M 11.86B 174M 1.2B 467M 6.06B 471M 461M 19.52B |
| Net income | -420M -361M -339M -310M -579M -39.7B -584M -4.01B -1.56B -20.29B -1.58B -1.54B -65.35B | -374M -322M -302M -277M -516M -35.39B -520M -3.58B -1.39B -18.09B -1.41B -1.38B -58.25B |
| Net Debt | -338M -291M -273M -250M -466M -31.96B -470M -3.23B -1.26B -16.34B -1.27B -1.24B -52.61B | -376M -324M -304M -278M -519M -35.57B -523M -3.59B -1.4B -18.18B -1.41B -1.38B -58.55B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-03 | US$12.68 | -0.63% | 3,003,249 |
| 26-09-02 | US$12.76 | +0.59% | 3,245,595 |
| 26-09-01 | US$12.69 | -0.35% | 2,184,155 |
| 26-08-31 | US$12.73 | -1.09% | 2,925,419 |
| 26-08-28 | US$12.87 | -1.83% | 3,441,960 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NTLA Stock
Select your edition
All financial news and data tailored to specific country editions
